Data is not available at this time.
Xebio Holdings Co., Ltd. operates as a leading sporting goods retailer in Japan, leveraging a diversified store portfolio to cater to various consumer segments. The company's revenue model is anchored in both physical retail and e-commerce, with brands like Super Sports XEBIO, Victoria, and L-Breath targeting different niches—from mass-market sports equipment to premium golf and outdoor gear. Its multi-brand strategy allows it to capture demand across price points and demographics, while its digital platforms and community-focused initiatives like XSPOT enhance customer engagement. Xebio competes in Japan's fragmented sporting goods market by combining scale (with integrated mega stores) and specialization (through niche formats like golf and eyewear stores). The company further differentiates itself through ancillary services, including event promotion, consulting, and even operating a sports arena (Xebio Arena), which strengthens its ecosystem. While facing competition from generalist retailers and online players, Xebio's vertical integration—spanning retail, wholesale, and even a hockey team—provides a unique market position. Its focus on experiential retail and community-building (e.g., Free Blades hockey team) aligns with broader industry trends toward lifestyle branding.
Xebio reported revenue of ¥242.4 billion for FY2024, with net income of ¥2.6 billion, reflecting a modest net margin of approximately 1.1%. Operating cash flow stood at ¥4.3 billion, though capital expenditures of ¥4.3 billion nearly offset this, indicating heavy reinvestment in store networks or digital infrastructure. The company's profitability metrics suggest operational leverage challenges, likely due to competitive pricing and store upkeep costs.
Diluted EPS of ¥58.32 underscores modest earnings power relative to its market cap. The near-parity of operating cash flow and capex implies limited free cash flow generation, though the low debt-to-equity ratio (total debt of ¥9.95 billion against cash reserves of ¥24.9 billion) indicates prudent capital management. The beta of 0.357 suggests lower volatility compared to the broader market.
Xebio maintains a robust balance sheet, with cash and equivalents (¥24.9 billion) exceeding total debt (¥9.95 billion), providing liquidity flexibility. The negligible net debt position and healthy current ratio (implied by cash reserves) signal strong financial health, reducing near-term solvency risks despite sector cyclicality.
Growth appears tempered, with revenue scale not translating into high-margin expansion. The dividend payout (¥30 per share) suggests a shareholder-friendly policy, though yield remains modest given the stock price. Future growth may hinge on digital adoption and niche store formats, but macroeconomic pressures in Japan's retail sector could weigh on discretionary spending.
At a market cap of ¥49 billion, Xebio trades at a P/E of ~19x (based on diluted EPS), aligning with specialty retail peers. The low beta implies muted market expectations for explosive growth, likely pricing in steady but slow sector recovery post-pandemic.
Xebio's multi-format retail strategy and community-centric initiatives (e.g., Xebio Arena) provide differentiation, but margin pressures persist. Success depends on optimizing its hybrid physical-digital model and leveraging Japan's sports culture. Near-term headwinds include consumer spending softness, though its strong balance sheet offers resilience.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |